UV Flu Technologies (UVFT) stock price, revenue, and financials

UV Flu Technologies market cap is $670.6 k, and annual revenue was $175.51 k in FY 2015

$670.6 K

UVFT Mkt cap, 15-Jan-2021

$53 K

UV Flu Technologies Revenue Q2, 2016
UV Flu Technologies Gross profit (Q2, 2016)26 K
UV Flu Technologies Gross profit margin (Q2, 2016), %49.2%
UV Flu Technologies Net income (Q2, 2016)-115.5 K
UV Flu Technologies EBIT (Q2, 2016)-89.3 K
UV Flu Technologies Cash, 31-Mar-20163.3 K
UV Flu Technologies EV914.4 K

UV Flu Technologies Revenue

UV Flu Technologies revenue was $175.51 k in FY, 2015

Embed Graph

UV Flu Technologies Income Statement

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015

Revenue

155.7k155.9k213.8k113.7k175.5k

Cost of goods sold

80.0k71.2k116.9k107.5k155.6k

Gross profit

75.8k84.6k96.9k6.2k19.9k

Gross profit Margin, %

49%54%45%5%11%

Sales and marketing expense

53.6k32.3k

General and administrative expense

146.3k845.5k1.0m1.0m949.9k

Operating expense total

860.3k849.2k1.0m1.0m949.9k

Depreciation and amortization

1.5k4.1k

EBIT

(784.6k)(764.6k)(911.6k)(1.0m)(930.0k)

EBIT margin, %

(504%)(491%)(426%)(894%)(530%)

Interest expense

64.5k84.1k

Pre tax profit

(337.7k)(322.0k)

Income tax expense

Net Income

(849.1k)(821.7k)(946.7k)(993.4k)(946.7k)

UV Flu Technologies Balance Sheet

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015

Cash

9.5k19.9k7.9k4.7k12.8k

Accounts Receivable

3.3k13.2k670.041.0k

Prepaid Expenses

107.2k160.1k18.4k7.5k9.6k

Inventories

114.4k133.0k255.0k170.9k73.4k

Current Assets

234.4k326.2k281.9k183.2k136.7k

PP&E

6.7k5.7k4.3k40.6k29.7k

Total Assets

241.1k331.9k286.2k223.8k166.4k

Accounts Payable

126.3k54.9k91.2k264.4k331.4k

Short-term debt

158.4k96.2k83.0k315.1k314.8k

Current Liabilities

284.6k151.1k174.2k914.3k

Long-term debt

12.3k6.1k135.0k

Total Debt

170.7k102.3k218.0k315.1k314.8k

Total Liabilities

914.3k849.8k

Common Stock

83.8k46.9k61.6k73.9k85.0k

Additional Paid-in Capital

1.4m2.5m3.2m3.5m4.0m

Retained Earnings

(5.3m)

Total Equity

(55.9k)174.7k(23.0k)(690.5k)(683.5k)

Financial Leverage

-4.3 x1.9 x-12.4 x-0.3 x-0.2 x

Quarterly

USDQ3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016

Cash

6.2k7.8k1.2k31.7k32.6k18.0k2.2k27.6k12.5k19.4k117.02.6k26.8k21.2k3.3k

Accounts Receivable

45.4k19.5k16.3k67.8k9.1k51.9k2.2k4.3k40.9k6.8k30.9k51.9k25.1k100.5k60.3k

Prepaid Expenses

108.2k104.4k115.5k66.0k134.0k92.4k19.5k4.6k22.5k8.8k90.5k292.7k366.1k21.7k56.8k

Inventories

88.9k108.4k84.6k137.7k197.4k178.6k259.0k242.3k1.9m177.2k138.9k80.6k135.1k43.0k67.2k

Current Assets

248.7k240.1k217.5k303.3k373.1k340.8k283.0k278.8k265.1k212.2k260.4k427.7k553.2k186.5k187.5k

PP&E

3.0k6.5k6.1k6.0k5.3k4.9k5.4k4.3k4.3k4.3k35.7k33.7k30.8k27.6k25.6k

Total Assets

252.7k246.6k223.6k309.3k378.5k345.8k288.3k283.0k269.4k216.5k296.1k461.4k584.0k214.1k213.1k

Accounts Payable

224.9k86.0k101.4k83.0k51.4k53.7k66.6k70.9k89.2k217.0k346.4k362.0k338.6k193.2k171.1k

Short-term debt

238.7k138.4k134.6k40.9k111.1k96.2k127.1k246.6k235.8k294.7k314.8k314.8k314.8k233.3k233.3k

Current Liabilities

463.6k224.4k235.9k123.9k162.5k194.9k193.8k317.5k325.0k511.7k1.1m919.4k1.1m667.0k770.0k

Long-term debt

13.1k11.2k10.2k9.1k5.1k19.0k66.9k13.9k13.9k

Total Debt

251.7k149.7k144.7k50.0k116.2k115.2k194.1k246.6k235.8k294.7k314.8k314.8k314.8k247.1k247.1k

Total Liabilities

476.6k235.7k246.1k133.0k213.8k260.7k325.0k511.7k1.1m919.4k1.1m680.8k783.9k

Common Stock

67.9k132.7k34.6k45.2k52.4k56.5k59.2k67.4k69.3k73.9k75.1k85.0k85.0k132.3k132.7k

Additional Paid-in Capital

1.3m1.7m2.0m2.4m2.8m3.0m3.1m3.5m3.6m3.7m3.7m4.0m4.0m4.8m4.8m

Retained Earnings

(5.4m)(5.5m)

Total Equity

(233.9k)(10.9k)(22.4k)176.4k210.8k132.0k27.6k(34.4k)(55.6k)(295.2k)(767.2k)(458.0k)(556.1k)(466.7k)(570.8k)

Financial Leverage

-1.1 x-22.5 x-10 x1.8 x1.8 x2.6 x10.4 x-8.2 x-4.8 x-0.7 x-0.4 x-1 x-1.1 x-0.5 x-0.4 x

UV Flu Technologies Cash Flow

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015

Net Income

(849.1k)(821.7k)(946.7k)(993.4k)(946.7k)

Depreciation and Amortization

670.01.5k1.5k4.1k10.9k

Accounts Receivable

7.0k(9.9k)16.5k670.0(41.0k)

Inventories

(5.1k)(18.6k)(122.0k)84.2k97.5k

Accounts Payable

(42.8k)53.7k54.0k289.1k149.8k

Cash From Operating Activities

(336.6k)(524.0k)(299.4k)(427.6k)(379.7k)

Purchases of PP&E

(4.0k)(457.0)(68.0)(382.0)

Cash From Investing Activities

(4.0k)86.2k(68.0)(382.0)

Short-term Borrowings

(4.3k)(363.0)

Cash From Financing Activities

350.2k448.3k287.4k424.8k387.8k

Net Change in Cash

9.5k10.4k(12.1k)(3.1k)8.0k

Interest Paid

1.0k35.9k15.0k1.5k

Income Taxes Paid

UV Flu Technologies Ratios

USDQ3, 2011

Financial Leverage

-1.1 x